2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 15.190 | 13.900 | 22.758 | 44.020 | 71.686 | 77.995 | 106.942 | 144.923 | 180.532 | 214.301 |
Total Income - EUR | 15.190 | 13.900 | 22.758 | 44.020 | 73.971 | 81.449 | 107.128 | 146.353 | 186.591 | 214.316 |
Total Expenses - EUR | 11.948 | 12.243 | 18.832 | 36.363 | 49.893 | 61.605 | 73.492 | 98.917 | 134.049 | 163.969 |
Gross Profit/Loss - EUR | 3.242 | 1.657 | 3.925 | 7.658 | 24.078 | 19.845 | 33.636 | 47.436 | 52.542 | 50.347 |
Net Profit/Loss - EUR | 2.786 | 1.240 | 3.698 | 7.217 | 23.360 | 19.065 | 32.921 | 46.243 | 51.006 | 48.523 |
Employees | 2 | 2 | 3 | 3 | 5 | 4 | 3 | 4 | 5 | 5 |
Check the financial reports for the company - Vetisan Med S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 5.738 | 44.818 | 39.062 | 32.039 | 28.054 | 55.354 | 78.000 |
Current Assets | 6.315 | 7.886 | 12.443 | 15.623 | 14.013 | 23.751 | 59.212 | 109.562 | 118.691 | 131.134 |
Inventories | 3.828 | 4.458 | 2.911 | 7.335 | 7.413 | 17.010 | 26.592 | 53.988 | 55.037 | 54.806 |
Receivables | 988 | 0 | 156 | 7.975 | 967 | 1.814 | 0 | 1.783 | 2.617 | 381 |
Cash | 1.499 | 3.428 | 9.375 | 312 | 5.633 | 4.927 | 32.620 | 53.791 | 61.037 | 75.947 |
Shareholders Funds | 5.340 | 6.625 | 10.255 | 17.298 | 40.341 | 56.517 | 88.367 | 132.650 | 171.261 | 204.102 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 975 | 1.261 | 2.188 | 4.064 | 18.491 | 6.360 | 2.924 | 5.032 | 2.823 | 5.065 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Vetisan Med S.r.l.